Mr. Bing Chen is currently Vice President of AstraZeneca International Business Development and Venture Fund, Managing Director and Co-founder of AZ-CICC Healthcare Investment Fund.

He has successfully led a number of collaborations with both international and China local pharmaceutical companies, leveraging his extensive industry experiences and sharp business acumen. These collaborations cover multiple disease areas including Oncology, CVRM and Respiratory TAs, continuously driving business growth and supporting China's innovation to go global.

He also co-founded the AstraZeneca-CICC Healthcare Investment Fund, working together with strategic partner CICC Capital, dedicated to discovering and incubating local innovation, and providing high-quality empowerment for their development, unlocking tremendous value potential.

Prior to joining AstraZeneca, Mr. Bing Chen served at McKinsey & Company for nearly seven years as Associate Principal, Greater China Office.